References to Primary References
- Source Drug and Market Development March 23, 19919–15.
- Sosin DM, Sacks JJ, Smith SM J Am. Med. Assn. 1989 262 2251.
- A recent summary of current mechanistic targets for anti-ischaemic therapy can be found in Pharmacology of Cerebral Ischemia Krieglstein J Oberpichler H Wiss. Ver. mbHStuttgart 1990.
- Numerous patents included ‘anti-ischaemic’ among potential uses. This review concentrates on patents which either presented data demonstrating potential anticerebral ischaemic activity or disclosed new, relatively unexplored potential mechanisms for neuroprotection.
- Scantton B, Frost J, George P, Carter C, Benavides J Current Opin. Thera. Patents 1991 1 523.
- Choi DW Ann. Rev. Neurosci. 1990 13 171.
- Johnson G, Bigge CF Ann. Reports Med. Chem. 199126 11; Fidia Foundation Symposium Series, vol 5; Excitatory Amino Acids Meldrum BS Moroni F Simon RP Woods JH Raven PressNew York 1991.
- Pellegrini J, Chen H-SV, Lei SZ, Sucher NJ, Lipton SA21st Annual Meeting of the Society for Neuroscience, Nov. 10–15, 1991 New Orleans, LAA6.8.
- Reynolds IJ, Aizenman E21st Annual Meeting of the Society for Neuroscience, Nov. 10–15, 1991 New Orleans, LAA6.9.
- Hollmann M, Hartley M, Heineman S Science 1991 252 851.
- Ly AM, Michaelis EK Biochemistry 1991 30 4307.
- Moriyoshi M, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S Nature 1991 354 31.
- Ray R, Julien R, Gordon J, Blosser J21 st Annual Meeting of the Society for Neuroscience, Nov. 10–15, 1991 New Orleans, LAA163.3.
- Wenganack TM, Ordy JM, Bialobok P21st Annual Meeting of the Society for Neuroscience, Nov. 10–15, 1991 New Orleans, LAA194.21.
- Ordy JM, Thomas GJ, Bialobok P, Wenganack TM, Murray RJ, Dunlap WP21st Annual Meeting of the Society for Neuroscience, Nov. 10–15, 1991 New Orleans, LA A426.3.
- Priestley T, Wooduff GN, Kemp JA Br. J. Pharmacol. 1989 97 1315.
- Gill R, Lodge DXVth International Symposium on Cerebral Blood Flow, June 1–6, 1991 Miami, Fl.
- Garthwaite J Trends in Neurosci. 1991 14 60 For a recent review, see.
- McGeer EG, Shu SG Neurosci. Lett. 1990 112 348.
- Nobbs MS6th SCI-RSC Medicinal Chemistry Symposium, Sept. 8–11, 1991 Churchill CollegeCambridge, UK.
- Pontecorvo MJ, Karbon EW, Goode S, Clissold DB, Borosky SA, Patch RJ, Ferkany JW Brain Res. Bull. 1991 26 461.
- Norvicki JP, Gibald K, Alize F, Scatton B J. Cereb. Blood Flow and Metab. 1991 11 suppl 2 S311.
- Lambert PD, Woodruff GN, Hughes J, Hunter JC Mol. Neuropharmacol. 1991 1 77.
- Vanhoutte PM J. Cardiovascular Pharmacol. 1990 16 suppl 3 S15 For recent reviews, see.
- Joseph R, Tsering C, Grunfeld S, Welch KMA Stroke 1991 20 1448.
- Prehn JHM, Backhauss C, Karhoutley C, Nuglisch J, Peruche B, Rossberg C, Krieglstein J Eur. J. Pharmacol. 1991 203 213 For recent publications see.
- Ohno M, Yamamoto T, Watanabe S Neurosci. Lett. 1991 129 185.
- Globus MY-T, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg M J. Cereb. Blood Flow and Metab. 1989 9 892.
- Hoffman WE, Cheng MA, Thomas C, Baughman VL, Albrecht RF Anesth. Analg. 1991 73 460.
- Globus MY-T, Ginsberg M, Busto R Neurosci. Lett. 1991 127 39.
- Johansen FF, Christensen T, Jensen CV, Nathan T, Lambert JDC, Diemer NH Exp. Brain Res. 1991 84 529.
- Kumagae Y, Matsui Y J. Neurochem. 1991 56 1169.
- Scremen OU, Jenden DJ Stroke 1989 20 92.
- Scremin OU, Jenden DJ Stroke 1989 20 1524.
- Scremin OU Ann. Rev. Pharmacol. Toxicol. 1991 31 229 For a review see.
- Phillis JW, Walter GA, Simpson RE J. Neurochem. 1991 56 644 and references therin.
- Saccomano NA, Ganong AH Ann. Reports Med. Chem. 1991 26 33.
- Jacobsen EJ, McCall JM Ann. Reports Med. Chem. 1990 25 31 and references therin.
- Hall ED, Braughler JM, Yonkers PA, Smith SL, Linseman KL, Means ED, Scherch HM, Von Voightlander PF, Lahti RA, Jacobsen EJ J. Pharmacol. Exp. Ther. 1991 258 688.
- Schinstine M, Gage F Ann. Reports Med. Chem. 1990 25 245 For recent reviews, see.
- Urdal DL Ann. Reports Med. Chem. 1991 26 221.
- Shinego T, Mima T, Takakura K, Katoh G, Hashimoto Y, Furukawa S, Graham DI Adv. Behav. Biol. 1990 38B 467.
- Von Harrer G, Melnizky U, Wagner F Arzneim-Forsch. 1972 22 900.
- Trojanova M, Karasek F, Prozkova V, Mourek M Physiol. Bohemoslov. 1976 25 319.
- Anderson J Trends Neurosci. 1989 52 83.
- Mazzari S, Lipartiti SS, Fadda E, Koga T, Lazarro A, Leon A, Toffano G Pharmacology of Cerebral Ischemia Krieglstein J Oberpichler H Wiss Ver. mbHStuttgart 1990541–551 For a recent review on GM1 action see.
- Faden AI, Yum SW, Lemke M, Vink R J. Pharmacol. Exp. Ther. 1990 255 608.
- Takayuki O, Satoru S, Hiroshi S, Masashi THighlights Ubiquinone Res. Proc. Int. Symp. Biochem. Bioenerg. Clin. Appl. Ubiquinone 19891990214.
- Xu C, Xue D, Su MC, Du LF, Gu X, Yang CL, Liu F Peptides 1987 8 769.
- Kochanek PM, Nemoto EM, Evans RW, Schoettle RJ New Trends in Lipid Mediators Research Braquet P Karger 1990 4 220–240.
- Clark WM, Madden KP, Rothlein R, Zivin JA Stroke 1991 22 877.
- Clark WM, Madden KP, Rothlein R, Zivin JA J. Neurosurg. 1991 75 623.
- Jiyun L Drugs of the Future 1991 16 904.
References to Patent Literature
- Searle GD & Co, WO9108211-A.
- Searle GD & Co, EP436831-A.
- Nova Pharm Corp, US5049555A.
- Warner-Lambert Co, EP-446570-A.
- Searle GD & Co, US5055468-A.
- Bristol-Myers Squibb Co, US5064831-A.
- Shinogi Seiyaku KK, EP-456183-A.
- ICI Americas Inc, EP-441598-A.
- Fisons Corp, US5047541-A.
- Fisons Corp, WO9111995-A.
- State of Oregon, WO9113056-A.
- Univ of Oregon/Oregon Health Sci Univ, WO9112797-A.
- Sumimoto Pharm Co Ltd, EP-443862-A.
- Novo Nordisk AS, WO9116325-A.
- Merrell Dow Pharm, US5026700.
- Merrell Dow Pharm, EP-398283-A.
- Pfizer Inc, WO9112005-A.
- Pfizer Inc, WO9117156-A.
- Synthelabo, US5034104-A.
- Natural Product Sci, Inc, EP-436332-A.
- Pfizer Inc, US5037846.
- Neurosearch A/S, EP-432648-A.
- Neurosearch A/S, EP-451626-A.
- Merck & Co, EP-459561-A.
- Merrell Dow Pharm, EP-446699-A.
- Wellcome Fdn Ltd, EP-459829-A.
- Wellcome Fdn Ltd, EP-459830-A.
- Searle GD & Co., EP-449301-A.
- Searle GD & Co., WO9112247-A.
- Pfizer Inc, US5061728.
- Synthelabo, EP-461012-A.
- Rorer Int Inc, WO9116888-A.
- Dr Lo Zambeletti SpA, WO9108205-A.
- Dr Lo Zambeletti SpA, WO9108206-A.
- Dr Lo Zambeletti SpA, WO9117981-A.
- Roussel-Ulcef, EP-456279-A.
- Warner-Lambert Co, US5063242.
- Medicis Corp, US5025018.
- Eli Lilly & Co, EP-452074-A.
- Eli Lilly & Co, US5043341.
- BASF K & F Corp, US5030656.
- Fujisawa Pharm Co Ltd, EP-451538-A.
- Sandoz Ltd, EP-433239-A.
- Scras, GB2243829-A.
- Bristol-Myers Squibb Co, US5055470.
- Toa Eiyo Ltd, EP-444196.
- Wake Forest Univ, US5039678.
- Tanabe Seiyaku Co Ltd, EP-441539-A.
- Santen Pharm Co Ltd, EP-429676-A.
- Novo NordiskA/S WO9109032-A.
- Akzo N V, EP-458387-A.
- Neurex Corp, WO9107980-A.
- Hoechst A G, EP-435153-A.
- Hokuriku Pharm Co Ltd, EP-430025-A.
- Orion-yhtyma Oy, EP-444899-A.
- Biogal, WO9107420-A.
- Biomedica Foscama Ind, US5041568.
- Takeda Chemical Ind Ltd, EP-443588-A.
- Abbott Labs, WO9108744-A.
- Ueno Seiyaku Oyo Kenkyujo KKEP-435443-A.
- Univ of California, WO9110681-A.
- Synergen, US4997929.
- Fidia SpA, EP-446931-A.
- Fidia SpA, EP-444638-A.
- Zambon Group SpA, EP-454026-A.
- Yoda Res & Dev Co Ltd, EP-544093-A.
- Ebewe Arzneimittel GmbH, EP-452299-A.
- LaJolla Cancer Res Fdn, WO9111462-A.
- Fidia SpA, EP-433113-A.
- Fidia SpA, EP-457671-A.
- Sanofi, EP-458696-A.
- Sauter Labs SA, WO9118607-A.
- Fidia SpA, WO9107417-A.
- Dr William Schwabe GmbH & Co, EP-431536-A.
- Dr William Schwabe GmbH & Co, EP-431535-A.
- Fidia SpA, EP-455560-A.
- Sikiric P, EP-432400-A.
- Gorio A, EP-441106-A.
- Adir & Co, EP-446133-A.
- Genentech/Brigham and Women's Hospital, WO9108231-A.
- Perstorp AB/Siren, WO9109601-A.
- Perstorp A B, WO9109604-A.
- Bayer A G, DE4011695-A.
- Carter-Wallace Inc, US5055489.
- Suntory Ltd, EP-461343-A.
- Rhone-Poulenc Rorer SA, WO911892-A.